A high-throughput in vitro translation screen towards discovery of novel antimalarial protein translation inhibitors
Hella Baumann, Holly Matthews, Mengqiao Li, Jenny J. Hu, Keith R. Willison, Jake Baum
Abstract
Drugs that target protein synthesis are well-validated for use as antimicrobials, yet specific high throughput (HTP) methods to screen for those targeting malaria are lacking. Here, we have developed a cell free in vitro translation (IVT) assay for the human malaria parasite, Plasmodium falciparum, which reconstitutes the native parasite protein translation machinery. Combining clarified IVT lysate with a click beetle luciferase reporter gene fused to untranslated regions of Pf histidine-rich proteins (hrp)-2 and 3, the HTP IVT assay accurately reports protein translation in a 384-well plate format using a standard spectrofluorometer. We validate the assay as effective in detecting compounds targeting the ribosome, ribosome co-factors (elongation factor 2) and cytosolic tRNA synthetases as well as its ability to find translation inhibitors in a blind screen using a high-density assay format amenable for high throughput. This demonstrates an ability to reconstitute the breadth of the parasite eukaryotic protein translation machinery in vitro and use it as a powerful platform for antimalarial drug discovery.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved antimalarials.
Christine Moore Sheridan, Valentina Elizabeth Garcia, … Joseph L. DeRisi·Malaria JournalPeer-reviewed·Dec 1, 2018
- Single-cell quantitative bioimaging of P. berghei liver stage translation.
J. L. McLellan, W. Sausman, … K. K. Hanson·bioRxiv·Jul 5, 2023
- Multiscale effects of perturbed translation dynamics inform antimalarial design
- Translation inhibition efficacy does not determine the Plasmodium berghei liver stage antiplasmodial efficacy of protein synthesis inhibitors
James L. McLellan, Kirsten K. Hanson·Life Science AlliancePeer-reviewed·Apr 4, 2024
- A high content imaging assay for identification of specific inhibitors of native Plasmodium liver stage protein synthesis
James L. McLellan, Beatriz Morales-Hernandez, … Kirsten K. Hanson·Antimicrobial Agents and ChemotherapyPeer-reviewed·Sep 10, 2024
- Quinazoline-quinoline bisubstrate inhibitors target eukaryotic translation initiation factor 3 in Plasmodium falciparum
I. Dobrescu, E. Hammam, … F. Nardella·bioRxiv·Dec 10, 2022